Zydus receives final approval from the USFDA for Acetazolamide ER Capsules

Deepthi | Myequity news | Date : 17-01-2019 11:30:00 IST

Zydus Cadila has received the final approval from the USFDA to market Acetazolamide ER Capsules (US RLD — Diamox). It will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad.

Acetazolamide is a potent carbonic anhydrase inhibitor. Acetazolamide ER capsules are used to treat certain types of glaucoma (caused by increased ocular pressure) and to treat or prevent altitude sickness (acute mountain sickness).

About Zydus Cadila


Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.


More from Myequity